Idiopathic myelofibrosis (IMF), or agnogenic myeloid metaplasia, was diagnosed in a sexually mature male marmoset {Callithrix jacchus) based on the results of hematology and histopathologic evaluation of the bone marrow. The hematologic changes included pancytopenia, leukoerythroblastosis, anisocytosis, poikilocytosis, and giant platelets. Histopathologic evaluation of the bone marrow showed marked widespread fibrosis replacing hematopoietic cells and the presence of atypical megakaryocytes. In addition, slight multifocal osteolysis with an increase in serum alkaline phosphatase activity was observed. We believe this is the first report of IMF in a nonhuman primate species.
Animal Welfare Standards:
Federal Register55(158):33448–33531, 1990
2.
BernardDKnapkaJRenquistD:
The apparent reversal of a wasting syndrome by nutritional intervention in Saguinus mystax.
Lab Anim Sci38:282–288, 1988
3.
CharronDRoberLCoutyMBinetJ:
Biochemical and histological analysis of bone marrow collagen in myelofibrosis.
Brit J Hematol41:151–161, 1979
4.
HasselbalchHJunkerPLisseIBentsenKDRisteliLRisteliJ:
Serum markers for type IV collagen and type III procollagen in the myelofibrosis—osteomyelosclerosis syndrome and other chronic myeloproliferative disorders.
Am J Hematol23:101–111, 1986
5.
HawkeyCMHartMGJonesDM:
Clinical hematology of the common marmoset (Callithrix jacchus).
Am J Primatol3:179–199, 1982
6.
JacobsonRJSaloAFialkowPJ:
Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis.
Blood51:189–194, 1978
7.
LichtmanMA:
Idiopathic myelofibrosis (agnogenic myeloid metaplasia). In:
Williams Hematology,
ed. BeutlerELichtmanMACollerBSand KippsTJ,
5th ed., pp. 331–340.
McGraw-Hill, Inc, New York, NY,
1995
8.
McCarthyDM:
Fibrosis of bone marrow: content and causes.
Brit J Hematol59:1–7, 1985
9.
MorinML:
A different approach in examining a wasting syndrome.
Lab Anim12:36–41, 1983
10.
National Research Council.In:
NIH Guide for the Care and Use of Laboratory Animals.
PHS Publication (NIH) 8523, Bethesda, MD, 1985
11.
RameshwarPDennyTNSteinDGasconP:
Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines: potential role of interleukin-1 and TGF-beta.
J Immunol153:2819–2830, 1994
12.
ReillyJT:
Pathogenesis of idiopathic myelofibrosis: role of growth factors.
J Clin Path45:461–464, 1992
13.
ReillyJTWilsonGBarnettDWatmoreAPotterA:
Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis.
Br J Hematol88:575–581, 1994
14.
RichterBCLehnerNDMHenricksonRV:
Primates, biology and diseases of callitrichidae. In:
Laboratory Animal Medicine,
ed. FoxJGCohenBJand LoewFM,
pp. 363–364.
Academic Press, Inc, New York, NY,
1984
15.
SmithREChelmowskiMKSzaboEJ:
Myelofibrosis: a concise review of clinical and pathologic features and treatment.
Am J Hematol29:174–180, 1988
16.
ThieleJHolgadaoSChoritzHGeorgiiA:
Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases.
Virchows Arch [Cell Path]41:67–82, 1982
17.
ThieleJSteinbergTZankovichRFischerR:
Primary myelofibrosis—osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
Anticanc Res9:429–436, 1989
18.
ValliVEO:
The hematopoietic system. In:
Pathology of Domestic Animals,
ed. JubbKVFKennedyPCand PalmerN,
4th ed.,
vol. 3, p. 133.
Academic Press, Inc, New York, NY,
1993
19.
VarkiALottenbergRGriffithRReinhardE:
The syndrome of idiopathic myelofibrosis: a clinicopathologic review with emphasis on the prognostic variables predicting survival.
Medicine62:353–371, 1983
20.
WolfBCNeimanRS:
Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.
Blood65:803–809, 1985
